ASC valuations vary based on factors such as size, specialty mix, ownership structure, and buyer type. Recent reference points underscore how wide the premium has become for quality assets. Optum’s acquisition of Surgical Care Affiliates (SCA) occurred at approximately 16.5x EBITDA. Reports around AMSURG implied a multiple just north of 14x. The Ascension Health definitive agreement to acquire AMSURG – adding 250+ centers across 34 states – closed in Q2 2026 and represents the largest ASC transaction in recent memory. Strong industry tailwinds are driving significant demand for independent ambulatory surgery centers, while rising labor costs, staffing shortages, financing challenges, and operational complexity are increasing pressure on independent operators.
Read the full article: Is 2026 a Good Time to Sell Your ASC? Valuation Trends, Buyer Demand & Strategic Options for Surgery Center Owners //
Source: https://physiciangrowthpartners.com/market-update/2026-ambulatory-surgery-center-market-update/